Says phase III trials showed 'no unexpected safety findings'. Armed with new phase III data, GlaxoSmithKline (GSK) has said it is on course to file for approval of its rheumatoid arthritis candidate sirukumab in 2016. Sirukumab is an interleukin-6 (IL-6) inhibitor, and one of a crop of new drugs that GSK has said could add at least Â£6bn to its revenues in 2020. The drug has been partnered with Johnson & Johnson's Janssen Biologics unit since 2011.
Agencies covered by the FAC-P/PM program may require additional training and experience beyond the basic FAC-P/PM requirements. Additional training is training in support of the agencyâs mission or the requirements of a program and project managerâs specific position.
What are prerequisites? Prerequisites are minimum entry requirements for admission to a program. Subject prerequisites are specific subjects applicants need to have studied and passed at Queensland Year 12/matriculation level or equivalent. They are intended to ensure all persons entering a program have studied and achieved an appropriate level of knowledge in subject areas deemed necessary to undertake the program successfully. Applicants who satisfy the prerequisite requirements are then eligible to compete for a place on the basis of the entry rank allocated to their qualifications.